- Home
- JKHY vs SNN Comparison
JKHY vs SNN Comparison
Compare JKHY & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JKHY
- SNN
- Stock Information
- Founded
- JKHY 1976
- SNN 1856
- Country
- JKHY United States
- SNN United Kingdom
- Employees
- JKHY N/A
- SNN N/A
- Industry
- JKHY Retail: Computer Software & Peripheral Equipment
- SNN Industrial Specialties
- Sector
- JKHY Technology
- SNN Health Care
- Exchange
- JKHY Nasdaq
- SNN Nasdaq
- Market Cap
- JKHY 12.6B
- SNN 15.2B
- IPO Year
- JKHY N/A
- SNN 1999
- Fundamental
- Price
- JKHY $160.80
- SNN $33.23
- Analyst Decision
- JKHY Hold
- SNN Hold
- Analyst Count
- JKHY 9
- SNN 4
- Target Price
- JKHY $176.22
- SNN $33.50
- AVG Volume (30 Days)
- JKHY 1.1M
- SNN 681.6K
- Earning Date
- JKHY 11-04-2025
- SNN 10-30-2025
- Dividend Yield
- JKHY 1.44%
- SNN 2.20%
- EPS Growth
- JKHY 20.28
- SNN 59.91
- EPS
- JKHY 6.58
- SNN 0.56
- Revenue
- JKHY $2,419,044,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- JKHY $6.98
- SNN $7.85
- Revenue Next Year
- JKHY $6.45
- SNN $5.43
- P/E Ratio
- JKHY $24.44
- SNN $28.79
- Revenue Growth
- JKHY 7.75
- SNN 5.35
- 52 Week Low
- JKHY $144.12
- SNN $23.69
- 52 Week High
- JKHY $196.00
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- JKHY 62.60
- SNN 33.56
- Support Level
- JKHY $146.49
- SNN $31.83
- Resistance Level
- JKHY $164.83
- SNN $37.06
- Average True Range (ATR)
- JKHY 3.55
- SNN 0.54
- MACD
- JKHY 1.06
- SNN -0.33
- Stochastic Oscillator
- JKHY 79.58
- SNN 24.43
About JKHY Jack Henry & Associates Inc.
Jack Henry is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing for US banks and credit unions, with a focus on small and midsize banks. Jack Henry serves almost 1,000 banks and over 700 credit unions.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.